An alternative proposal to the destruction of abandoned human embryos

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Editors and Editorial Staff. Reprod. Biomed. Online 21, 725 https://doi.org/10.1016/j.rbmo.2010.10.004 (2010).

    Article  Google Scholar 

  2. 2

    Ethics Committee of the American Society for Reproductive Medicine. Fertil. Steril. 99, 1848–1849 (2013).

  3. 3

    Ethics Committee of the American Society for Reproductive Medicine. Fertil. Steril. 100, 935–939 (2013).

  4. 4

    Ethics Committee of the American Society for Reproductive Medicine. Fertil. Steril. 101, 332–335 (2014).

  5. 5

    ACOG Committee on Ethics. Obstet. Gynecol. 108, 1305–1317 (2006).

  6. 6

    Hoffman, D.I. et al. Fertil. Steril. 79, 1063–1069 (2003).

    Article  Google Scholar 

  7. 7

    Tonkens, R. Monash. Bioeth. Rev. 34, 52–69 (2016)

    Article  Google Scholar 

  8. 8

    Annas, G.J., Caplan, A. & Elias, S. N. Engl. J. Med. 334, 1329–1332 (1996).

    CAS  Article  Google Scholar 

  9. 9

    International Society for Stem Cell Research. Guidelines for Stem Cell Research and Translation. http://bit.ly/2mStq4r (May 12, 2016).

  10. 10

    Cohen, C.B. Stem Cell Rev. 5, 116–122 (2009).

    Article  Google Scholar 

  11. 11

    Kalista, T., Freeman, H.A., Behr, B., Pera, R.R. & Scott, C.T. Cell Stem Cell 8, 360–362 (2011).

    CAS  Article  Google Scholar 

  12. 12

    Samorinha, C., Pereira, M., Machado, H., Figueiredo, B. & Silva, S. Hum. Reprod. Update 20, 641–655 (2014).

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Norbert Gleicher.

Ethics declarations

Competing interests

N.G. is owner of The Center for Human Reproduction, a for-profit fertility center. He is co-inventor on a number of pending and already awarded US patents claiming therapeutic benefits from androgen supplementation in women with low functional ovarian reserve and relating to the FMR1 gene in a diagnostic function in female fertility. He receives royalties from Fertility Nutraceuticals, in which he also holds shares. N.G. is also a co-inventor of three pending AMH-related patent applications, and shareholder in OvaNova Laboratories.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gleicher, N., Caplan, A. An alternative proposal to the destruction of abandoned human embryos. Nat Biotechnol 36, 139–141 (2018). https://doi.org/10.1038/nbt.4070

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing